eMedicine Specialties > Pediatrics: General Medicine > Parasitology

Amebic Meningoencephalitis: Differential Diagnoses & Workup

Author: Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Contributor Information and Disclosures

Updated: Jan 21, 2009

Differential Diagnoses

Amebiasis
Mixed Connective Tissue Disease
Astrocytoma
Mucormycosis
Catscratch Disease
Neurocysticercosis
Coccidioidomycosis
Periventricular Hemorrhage-Intraventricular Hemorrhage
Craniopharyngioma
Polyarteritis Nodosa
Echinococcosis
Rabies
Gnathostomiasis
Taenia Infection
Histoplasmosis
Toxoplasmosis
Malaria
Tuberculosis
Medulloblastoma
Vasculitis and Thrombophlebitis
Meningitis, Aseptic
Meningitis, Bacterial
Meningococcal Infections

Other Problems to Be Considered

Angiostrongylus cantonensis
Baylisascaris procyonis

Brain abscess
Cryptococcosis
Cysticercus cellulosae
Encephalitis
Intracranial hemorrhage
Sappinia diploidea

Workup

Laboratory Studies

  • Primary amebic meningoencephalitis (PAM): Lumbar puncture for cerebrospinal fluid (CSF) analysis is the primary diagnostic tool.
    • CSF analysis is indistinguishable from that in acute bacterial meningitis, except that Gram stain findings are always negative.
    • A predominance of neutrophils is observed, with elevated protein levels, decreased glucose levels, and RBCs present.
    • If PAM is suspected, light microscopy with phase contrast on fresh, still-warm CSF may reveal motile trophozoites.
    • Recently, a triplex real-time polymerase chain reaction (PCR) assay for Naegleria, Acanthamoeba, and Balamuthia has been developed by the Centers for Disease Control and Prevention (CDC).5
  • Granulomatous amebic encephalitis (GAE): Lumbar puncture for CSF analysis is the primary diagnostic tool.
    • CSF analysis typically demonstrates less inflammation than that observed in individuals with PAM.
    • Opening pressure is elevated.
    • CSF analysis mimics that of aseptic meningitis, with low-to-moderate, primarily mononuclear WBCs; elevated protein levels; and, often, near-normal or slightly decreased glucose levels.
    • No trophozoites appear in the CSF.
    • Recently, a triplex real-time PCR assay for Naegleria, Acanthamoeba, and Balamuthia has been developed by the CDC.5

Imaging Studies

  • CT or MRI
    • Head CT scanning or MRI should precede lumbar puncture if evidence of focal CNS involvement or elevated intracranial pressure (ICP) is present.
    • CT and MRI frequently reveal meningeal hyperemia and cerebral edema.
    • Imaging studies may reveal evidence of increased ICP or cerebral herniation.
    • In an individual with PAM, the olfactory bulbs, temporal lobes, and frontal lobes are involved; however, disease may be diffuse.
  • In individuals with GAE, focal lesions are very common and may be found throughout the CNS.

Procedures

  • A biopsy of focal granulomatous lesions in persons with GAE may assist in making the diagnosis.

Histologic Findings

  • Biopsies or postmortem specimens from persons with PAM reveal the intense inflammation with invasion of polymorphonuclear leukocytes, hemorrhage, and necrosis typical of acute meningitis.
  • Fluorescent antibodies may help to identify the numerous trophozoites present.
  • In individuals with GAE, moderate granulomatous inflammation with prominent vascular involvement is typically present.
  • Both trophozoites and cysts, which are less numerous, can be identified through the use of fluorescent antibodies.
  • Recently, tissue-based PCR has been proposed as a diagnostic aid.5

More on Amebic Meningoencephalitis

Overview: Amebic Meningoencephalitis
Differential Diagnoses & Workup: Amebic Meningoencephalitis
Treatment & Medication: Amebic Meningoencephalitis
Follow-up: Amebic Meningoencephalitis
References
Further Reading

References

  1. Cermeno JR, Hernandez I, El Yasin H, et al. Meningoencephalitis by Naegleria fowleri: epidemiological study in Anzoategui state, Venezuela. Rev Soc Bras Med Trop. May-Jun 2006;39(3):264-8. [Medline].

  2. Bakardjiev A, Azimi PH, Ashouri N, et al. Amebic encephalitis caused by Balamuthia mandrillaris: report of four cases. Pediatr Infect Dis J. May 2003;22(5):447-53. [Medline].

  3. Craun GF, Calderon RL, Craun MF. Outbreaks associated with recreational water in the United States. Int J Environ Health Res. Aug 2005;15(4):243-62. [Medline].

  4. Deetz TR, Sawyer MH, Billman G, et al. Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin Infect Dis. Nov 15 2003;37(10):1304-12. [Medline].

  5. Qvarnstrom Y, Visvesvara GS, Sriram R, da Silva AJ. Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol. Oct 2006;44(10):3589-95. [Medline][Full Text].

  6. Goswick SM, Brenner GM. Activities of Azithromycin and Amphotericin B against Naegleria fowleri In Vitro and in a Mouse Model of Primary Amebic Meningoencephalitis. Antimicrob Agents Chemother. Feb 2003;47(2):524-8. [Medline][Full Text].

  7. Soltow SM, Brenner GM. Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother. Jan 2007;51(1):23-7. [Medline].

  8. AAP. Amebic meningoencephalitis and keratitis. In: Red Book: Report of the Committee on Infectious Diseases. 2006:206-8.

  9. Apley J, Clarke SK, Roome AP, et al. Primary amoebic meningoencephalitis in Britain. Br Med J. Mar 7 1970;1(696):596-9. [Medline].

  10. Bloch KC, Schuster FL. Inability to make a premortem diagnosis of Acanthamoeba species infection in a patient with fatal granulomatous amebic encephalitis. J Clin Microbiol. Jun 2005;43(6):3003-6. [Medline][Full Text].

  11. CDC. Primary amebic meningoencephalitis--Arizona, Florida, and Texas, 2007. MMWR Morb Mortal Wkly Rep. May 30 2008;57(21):573-7. [Medline].

  12. Cervantes-Sandoval I, Serrano-Luna Jde J, Garcia-Latorre E, Tsutsumi V, Shibayama M. Characterization of brain inflammation during primary amoebic meningoencephalitis. Parasitol Int. Sep 2008;57(3):307-13. [Medline].

  13. Cha JH, Furie K, Kay J, et al. Case records of the Massachusetts General Hospital. Case 39-2006. A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness. N Engl J Med. Dec 21 2006;355(25):2678-89. [Medline].

  14. Chotmongkol V, Sawanyawisuth K, Thavornpitak Y. Corticosteroid treatment of eosinophilic meningitis. Clin Infect Dis. Sep 2000;31(3):660-2. [Medline].

  15. Cogo PE, Scagli M, Gatti S, et al. Fatal Naegleria fowleri meningoencephalitis, Italy. Emerg Infect Dis. Oct 2004;10(10):1835-7. [Medline].

  16. Durack DT. Amebic infections. In: Infections of the Central Nervous System. 1997:831-44.

  17. Dziuban EJ, Liang JL, Craun GF, et al. Surveillance for waterborne disease and outbreaks associated with recreational water--United States, 2003-2004. MMWR Surveill Summ. Dec 22 2006;55(12):1-30. [Medline].

  18. Fritzinger AE, Toney DM, MacLean RC, Marciano-Cabral F. Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody. Infect Immun. Feb 2006;74(2):1189-95. [Medline].

  19. Gavin PJ, Shulman ST. Raccoon roundworm (Baylisascaris procyonis). Pediatr Infect Dis J. Jul 2003;22(7):651-2. [Medline].

  20. Gelman BB, Rauf SJ, Nader R, et al. Amoebic encephalitis due to Sappinia diploidea. JAMA. May 16 2001;285(19):2450-1. [Medline].

  21. Grate I Jr. Primary amebic meningoencephalitis: a silent killer. CJEM. Sep 2006;8(5):365-9. [Medline].

  22. Gyori E. December 2002: 19-year old male with febrile illness after jet ski accident. Brain Pathol. Apr 2003;13(2):237-9. [Medline].

  23. Hara T, Fukuma T. Diagnosis of the primary amoebic meningoencephalitis due to Naegleria fowleri. Parasitol Int. Dec 2005;54(4):219-21. [Medline].

  24. Hebbar S, Bairy I, Bhaskaranand N, et al. Fatal case of Neagleria fowleri meningo-encephalitis in an infant: case report. Ann Trop Paediatr. 2005;25:223-6. [Medline].

  25. Houpt ER, Petri WA Jr. Acanthamoeba species. In: Principles and Practice of Pediatric Infectious Diseases. 2003:1293-5.

  26. Huang ZH, Ferrante A, Carter RF. Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis. J Infect Dis. May 1999;179(5):1305-8. [Medline].

  27. Hughes MA, Petri WA Jr. Naegleria fowleri. In: Principles and Practice of Pediatric Infectious Diseases. 2003:1291-3.

  28. Intalapaporn P, Suankratay C, Shuangshoti S, et al. Balamuthia mandrillaris meningoencephalitis: the first case in southeast Asia. Am J Trop Med Hyg. Jun 2004;70(6):666-9. [Medline][Full Text].

  29. Jayasekera S, Sissons J, Tucker J, et al. Post-mortem culture of Balamuthia mandrillaris from the brain and cerebrospinal fluid of a case of granulomatous amoebic meningoencephalitis, using human brain microvascular endothelial cells. J Med Microbiol. Oct 2004;53(Pt 10):1007-12. [Medline][Full Text].

  30. Karanis P, Kourenti C, Smith H. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J Water Health. Mar 2007;5(1):1-38. [Medline].

  31. Kaushal V, Chhina DK, Ram S, Singh G, Kaushal RK, Kumar R. Primary amoebic meningoencephalitis due to Naegleria fowleri. J Assoc Physicians India. Jun 2008;56:459-62. [Medline].

  32. Kim JH, Jung SY, Lee YJ, et al. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri. Antimicrob Agents Chemother. Nov 2008;52(11):4010-6. [Medline].

  33. Kim JH, Lee YJ, Sohn HJ, et al. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri. Int J Antimicrob Agents. Nov 2008;32(5):411-7. [Medline].

  34. Li Q, Yang XH, Qian J. September 2004: a 6-year-old girl with headache and stiff neck. Brain Pathol. Jan 2005;15(1):93-5. [Medline].

  35. Lo Re V 3rd, Gluckman SJ. Eosinophilic meningitis due to Angiostrongylus cantonensis in a returned traveler: case report and review of the literature. Clin Infect Dis. Nov 1 2001;33(9):e112-5. [Medline].

  36. Ma P, Visvesvara GS, Martinez AJ, et al. Naegleria and Acanthamoeba infections: review. Rev Infect Dis. May-Jun 1990;12(3):490-513. [Medline].

  37. Marciano-Cabral F. Advances in free-living amebae research 2006: summary from the IX International Workshop on Opportunistic Protists (IWOP-9). J Eukaryot Microbiol. 2006;53 Suppl 1:S8-9. [Medline].

  38. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as Agents of Disease in Humans. Clin Microbiol Rev. Apr 2003;16(2):273-307. [Medline].

  39. Marciano-Cabral F, Cabral GA. The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Immunol Med Microbiol. Nov 2007;51(2):243-59. [Medline].

  40. Maurer DM, Greene JP, Vincent JM, et al. Fever, refusal to walk and eosinophilia in a ten-month-old Samoan boy. Pediatr Infect Dis J. Feb 2001;20(2):230-1, 232-3. [Medline].

  41. McKee T, Davis L, Blake P. Primary amebic meningoencephalitis--Georgia, 2002. MMWR Morb Mortal Wkly Rep. Oct 10 2003;52(40):962-4. [Medline].

  42. McKellar MS, Mehta LR, Greenlee JE. Fatal granulomatous Acanthamoeba encephalitis mimicking a stroke, diagnosed by correlation of results of sequential magnetic resonance imaging, biopsy, in vitro culture, immunofluorescence analysis, and molecular analysis. J Clin Microbiol. Nov 2006;44(11):4265-9. [Medline].

  43. Meersseman W, Lagrou K, Sciot R, de Jonckheere J, Haberler C, Walochnik J. Rapidly fatal Acanthamoeba encephalitis and treatment of cryoglobulinemia. Emerg Infect Dis. Mar 2007;13(3):469-71. [Medline].

  44. Mendez O, Kanal E, Abu-Elmagd KM. Granulomatous amebic encephalitis in a multivisceral transplant recipient. Eur J Neurol. Mar 2006;13(3):292-5. [Medline].

  45. Moertel CL, Kazacos KR, Butterfield JH, et al. Eosinophil-associated inflammation and elaboration of eosinophil- derived proteins in 2 children with raccoon roundworm (Baylisascaris procyonis) encephalitis. Pediatrics. Nov 2001;108(5):E93. [Medline][Full Text].

  46. Ondarza RN. Drug targets from human pathogenic amoebas: Entamoeba histolytica, Acanthamoeba polyphaga and Naegleria fowleri. Infect Disord Drug Targets. Sep 2007;7(3):266-80. [Medline].

  47. Park SY, Glaser C, Murray WJ, et al. Raccoon roundworm (Baylisascaris procyonis) encephalitis: case report and field investigation. Pediatrics. Oct 2000;106(4):E56. [Medline].

  48. Perez MT, Bush LM. Balamuthia mandrillaris Amebic Encephalitis. Curr Infect Dis Rep. Jul 2007;9(4):323-8. [Medline].

  49. Perez MT, Bush LM. Fatal amebic encephalitis caused by Balamuthia mandrillaris in an immunocompetent host: a clinicopathological review of pathogenic free-living amebae in human hosts. Ann Diagn Pathol. Dec 2007;11(6):440-7. [Medline].

  50. Petry F, Torzewski M, Bohl J, et al. Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid. J Clin Microbiol. May 2006;44(5):1903-4. [Medline][Full Text].

  51. Robertson J, Shilkofski N. Drug doses. In: The Harriet Lane Handbook: A Manual for Pediatric House Officers. Philadelphia, Pa: Mosby; 2005:679-1009.

  52. Robinson BS, Monis PT, Dobson PJ. Rapid, sensitive, and discriminating identification of Naegleria spp. by real-time PCR and melting-curve analysis. Appl Environ Microbiol. Sep 2006;72(9):5857-63. [Medline].

  53. Schild M, Gianinazzi C, Gottstein B, Muller N. PCR-based diagnosis of Naegleria spp. infection in formalin-fixed and paraffin-embedded brain sections. J Clin Microbiol. Nov 22 2006;[Medline].

  54. Schuster FL. Cultivation of pathogenic and opportunistic free-living amebas. Clin Microbiol Rev. Jul 2002;15(3):342-54. [Medline].

  55. Schuster FL, Guglielmo BJ, Visvesvara GS. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol. Mar-Apr 2006;53(2):121-6. [Medline].

  56. Schuster FL, Yagi S, Wilkins PP, Gavali S, Visvesvara GS, Glaser CA. Balamuthia mandrillaris, agent of amebic encephalitis: detection of serum antibodies and antigenic similarity of isolates by enzyme immunoassay. J Eukaryot Microbiol. Jul-Aug 2008;55(4):313-20. [Medline].

  57. Seidel JS. Naegleria, Acanthamoeba, and Balamuthia. In: Textbook of Pediatric Infectious Diseases. 2004:2748-55.

  58. Seidel JS, Harmatz P, Visvesvara GS, et al. Successful treatment of primary amebic meningoencephalitis. N Engl J Med. Feb 11 1982;306(6):346-8. [Medline].

  59. Shirwadkar CG, Samant R, Sankhe M, et al. Acanthamoeba encephalitis in patient with systemic lupus, India. Emerg Infect Dis. Jun 2006;12(6):984-6. [Medline].

  60. Singh P, Kochhar R, Vashishta RK, et al. Amebic meningoencephalitis: spectrum of imaging findings. AJNR Am J Neuroradiol. Jun-Jul 2006;27(6):1217-21. [Medline].

  61. Singhal T, Bajpai A, Kalra V, et al. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr Infect Dis J. Jun 2001;20(6):623-7. [Medline].

  62. Siripanth C. Amphizoic amoebae: pathogenic free-living protozoa; review of the literature and review of cases in Thailand. J Med Assoc Thai. 2005;88:701-7. [Medline].

  63. Slom TJ, Cortese MM, Gerber SI, et al. An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean. N Engl J Med. Feb 28 2002;346(9):668-75. [Medline].

  64. Stephany JD, Pearl GS, Gonzalez OR. Pathologic quiz case: headache in an 8-year-old child. Primary amebic meningoencephalitis due to Naegleria fowleri. Arch Pathol Lab Med. Feb 2004;128(2):e33-4. [Medline].

  65. Tungikar SL, Kulkarni AG, Deshpande AD, Gosavi VS. Primary amebic meningoencephalitis. J Assoc Physicians India. Apr 2006;54:327-9. [Medline].

  66. Vargas-Zepeda J, Gomez-Alcala AV, Vasquez-Morales JA, et al. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res. Jan-Feb 2005;36(1):83-6. [Medline].

  67. Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol. Jun 2007;50(1):1-26. [Medline].

  68. Walker MD, Zunt JR. Neuroparasitic infections: cestodes, trematodes, and protozoans. Semin Neurol. Sep 2005;25(3):262-77. [Medline].

  69. Wiwanitkit V. Review of clinical presentations in Thai patients with primary amoebic meningoencephalitis. Medscape Gen Med. 2004;6(1):[Full Text].

  70. Yoder JS, Blackburn BG, Craun GF, et al. Surveillance for waterborne-disease outbreaks associated with recreational water--United States, 2001-2002. MMWR Surveill Summ. Oct 22 2004;53(8):1-22. [Medline].

  71. Yoder JS, Hlavsa MC, Craun GF, et al. Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events--United States, 2005-2006. MMWR Surveill Summ. Sep 12 2008;57(9):1-29. [Medline].

Further Reading

Keywords

amebic meningoencephalitis, acanthamebic keratoconjunctivitis, Acanthamoeba, aphasia, aseptic meningitis, ataxia, bacterial meningitis, Balamuthia mandrillaris, central nervous system infection, CNS infection, cerebral herniation, cranial nerve palsies, diplopia, encephalitis, Entamoeba histolytica, granulomatous amebic encephalitis, GAE, hemiplegias, intracranial pressure, ICP, leptomyxid meningitis, meningitis, myocarditis, Naegleria fowleri, photophobia, primary amebic meningoencephalitis, PAM, Sappinia diploidea

Contributor Information and Disclosures

Author

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Consulting; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching; sanofi pasteur Grant/research funds Unrestricted research grant; sanofi pasteur  Consulting; sanofi pasteur Honoraria Speaking and teaching; Tap Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching

Medical Editor

Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA, Associate Professor in Biomolecular, Biomedical Science & Health, Griffith University; Director of Infectious Diseases and Unit Head of Queensland Paediatric Infectious Laboratory, Sir Albert Sakzewski Viral Research Centre, Royal Children's Hospital
Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Pediatric Infectious Diseases Society, Royal Australasian College of Physicians, and Royal College of Pathologists of Australasia
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Martin Weisse, MD, Program Director, Associate Professor, Department of Pediatrics, West Virginia University
Martin Weisse, MD is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

CME Editor

David Pallares, MD, Clinical Assistant Professor, Department of Pediatrics, Division of Allergy and Immunology, University of Louisville
David Pallares, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology
Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.